Search | Page 2 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft versus host disease after allogeneic stem cell transplantation for acquired aplastic anemia.

    ... (MSD) (n=21) and unrelated donors, UD (n=29), using fludarabine 30mg/m(2) for 4 days, cyclophosphamide 300mg/m(2) for ...

    Research Article last updated 10/11/2011 - 5:58pm.

  2. PRO#1278: Fludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation (FLUBUTBI)

    ... This is a single institution study of fludarabine and busulfan versus fludarabine, busulfan and low dose total body irradiation in patients ...

    Clinical Trial last updated 04/29/2016 - 3:09pm.

  3. Clofarabine in the treatment of myelodysplastic syndromes.

    ... at least two prior regimens. Clofarabine is a hybrid of fludarabine and cladribine, designed to overcome the pharmacologic ...

    Research Article last updated 02/04/2014 - 2:18pm.

  4. Optimizing Cord Blood and Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502) (CHAMP)

    ... Filgrastim Fludarabine Mycophenolate Mofetil ...

    Clinical Trial last updated 05/22/2017 - 11:00am.

  5. Second allogeneic hematopoietic stem cell transplantation in children with severe aplastic anemia

    ... patients who were conditioned with regimens containing fludarabine and melphalan were alive with hematopoietic recovery. These ...

    Research Article last updated 07/08/2015 - 10:10am.

  6. Good outcome of haploidentical hematopoietic SCT as a salvage therapy in children and adolescents with acquired severe aplastic anemia

    ... our center. The conditioning regimen consisted of BU, fludarabine , CY and anti-thymocyte globulin. All patients received ...

    Research Article last updated 09/04/2014 - 11:22am.

  7. Long-term outcome of fludarabine-based reduced intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuria

    ... transplant (HCT). All received cyclophosphamide / fludarabine +/- ATG followed by a G-CSF mobilized HCT from an HLA-matched ...

    Research Article last updated 06/02/2014 - 11:39am.

  8. Reduced intensity conditioning, combined transplantation of haploidentical hematopoietic stem cells and mesenchymal stem cells in patients with severe aplastic anemia

    ... Reduced intensity conditioning consisted of fludarabine (30 mg/m2·d)+cyclosphamide (500 mg/m2·d)+anti-human ...

    Research Article last updated 04/09/2014 - 9:16am.

  9. Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemia

    ... We piloted a risk-adapted AlloHSCT approach, using fludarabine and anti-thymocyte globulin based conditioning with high ...

    Research Article last updated 04/09/2014 - 9:11am.

  10. Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels

    ... of cyclophosphamide (CY) dose deescalation in a fludarabine -based conditioning regimen for bone marrow ... received fixed doses of antithymocyte globulin , fludarabine, and low-dose total body irradiation. The starting CY dose was 150 ...

    Research Article last updated 07/30/2012 - 1:47pm.